This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Novartis: A Transformative Deal
Collis, David J.; Hartman, AshleyCase HBS-717453-EStrategyWhen Joe Jimenez became CEO of Swiss-based Novartis in 2010 replacing longtime CEO Dan Vasella, he assumed control of one of the top pharmaceutical companies in the world. Vasella, an avowed advocate of diversification, had expanded the scope of the company and structured it into sixteen distinct business units ranging from animal health to oncology while "actively fostering competition between those divisions for resources." Shortly after assumi...Starting at €8.20
-
Group Functions at the Maersk Group (Spanish version)
Collis, David J.; Shaffer, MatthewCase HBS-716S21StrategyIn 2014, seven years after he was appointed CEO of the Danish shipping and oil conglomerate A.P. M ller Maersk (the Maersk Group), Nils Andersen was reexamining the size and role of corporate headquarters in the company he had reshaped as a "premium conglomerate." During his tenure, Andersen had divided what had previously been operated as almost a single entity into separate lines of business, each accountable for its own performance and expect...Starting at €8.20
-
Group Functions at the Maersk Group
Collis, David J.; Shaffer, MatthewCase HBS-715432-EStrategyIn 2014, seven years after he was appointed CEO of the Danish shipping and oil conglomerate A.P. M ller Maersk (the Maersk Group), Nils Andersen was reexamining the size and role of corporate headquarters in the company he had reshaped as a "premium conglomerate." During his tenure, Andersen had divided what had previously been operated as almost a single entity into separate lines of business, each accountable for its own performance and expect...Starting at €8.20